Robert Barrow is CEO at Mind Medicine (MindMed) Inc. (MNMD). They have made 18 open-market trades across 1 company since 2022, most recently 2026-09-25.
CIK 0001897557
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2024, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DFTX | SELL · 10b5-1 | 2026-09-25 | 2026-09-29 | $36.57 | $1.2M | -3.5% | — | — |
| DFTX | SELL · 10b5-1 | 2026-09-03 | 2026-09-04 | $37.94 | $722K | +2.4% | -4.1% | — |
| DFTX | SELL · 10b5-1 | 2026-06-25 | 2026-06-26 | $45.03 | $1.3M | +7.2% | -5.6% | -18.7% |
| DFTX | SELL · 10b5-1 | 2026-03-25 | 2026-03-26 | $18.47 | $451K | +11.6% | +11.4% | +123.7% |
| MNMD | SELL · 10b5-1 | 2025-12-26 | 2025-12-29 | $13.15 | $678K | +2.8% | N/A | N/A |
| MNMD | SELL · 10b5-1 | 2025-09-25 | 2025-09-26 | $9.77 | $504K | +15.1% | +15.3% | +17.4% |
| MNMD | SELL · 10b5-1 | 2025-06-25 | 2025-06-26 | $6.80 | $360K | +15.1% | +44.3% | +46.3% |
| MNMD | SELL · 10b5-1 | 2025-03-25 | 2025-03-26 | $6.74 | $286K | -16.6% | -4.3% | +9.8% |
| MNMD | SELL · 10b5-1 | 2024-12-26 | 2024-12-27 | $7.43 | $284K | +5.0% | +4.5% | -2.6% |
| MNMD | SELL · 10b5-1 | 2024-09-25 | 2024-09-25 | $5.98 | $236K | -13.2% | +0.0% | +21.0% |
| MNMD | BUY | 2024-08-19 | 2024-08-20 | $6.22 | $6K | -3.0% | +1.0% | +9.4% |
| MNMD | SELL · 10b5-1 | 2024-06-25 | 2024-06-25 | $7.22 | $226K | -3.4% | +33.2% | -17.0% |
| MNMD | SELL · 10b5-1 | 2024-03-25 | 2024-03-26 | $9.50 | $314K | +9.2% | -14.5% | -26.0% |
| MNMD | SELL | 2023-12-26 | 2023-12-26 | $3.63 | $48K | +14.9% | -4.5% | +173.0% |
| MNMD | SELL | 2023-09-25 | 2023-09-25 | $3.58 | $48K | -13.0% | -26.6% | +9.3% |
| MNMD | SELL | 2023-06-27 | 2023-06-27 | $3.20 | $50K | +21.0% | +24.0% | +7.8% |
| MNMD | SELL | 2023-03-01 | 2023-03-02 | $3.51 | $29K | -15.7% | -16.2% | -2.7% |
| MNMD | SELL | 2022-12-21 | 2022-12-22 | $2.69 | $10K | +0.0% | +37.3% | +9.3% |
| MNMD | SELL | 2022-10-25 | 2022-10-25 | $2.81 | $3K | -6.3% | -2.1% | +25.2% |
| MNMD | SELL | 2022-10-18 | 2022-10-18 | $3.11 | $4K | -0.7% | -9.2% | +17.8% |
| MNMD | SELL | 2022-09-26 | 2022-09-27 | $5.51 | $7K | +1.3% | -4.6% | -25.3% |
| MNMD | SELL | 2022-09-16 | 2022-09-19 | $7.26 | $10K | -53.2% | -61.6% | -64.1% |
| MNMD | SELL | 2022-08-31 | 2022-09-01 | $11.67 | $14K | -31.4% | -71.6% | -78.1% |
| MNMD | SELL | 2022-08-16 | 2022-08-17 | $0.68 | $14K | -32.7% | -57.8% | -84.0% |
| MNMD | SELL | 2022-07-25 | 2022-07-26 | $0.69 | $13K | -12.6% | +18.2% | -74.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.